Mechanisms of divalent metal toxicity in affective disorders

Toxicology

Volumn 339, Issue , 2016, Pages 58-72

  Menon, Archita Venugopal ^a   Chang, JuOae ^a   Kim, Jonghan ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Cadmium; Divalent metal transporter 1; Emotion; Iron; Lead; Manganese

Indexed keywords

CADMIUM; IRON; LEAD; MANGANESE; METAL; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; DIVALENT CATION; DMRT1 PROTEIN; TRANSCRIPTION FACTOR;

BEHAVIOR CHANGE; BEHAVIOR DISORDER; BRAIN; CADMIUM POISONING; DISEASE ASSOCIATION; DNA POLYMORPHISM; ERYTHROID CELL; EXPOSURE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; INTESTINE; INTOXICATION; IRON DEFICIENCY; IRON OVERLOAD; KIDNEY; LEAD POISONING; LIFESTYLE; LIVER; MANGANESE DEFICIENCY; METAL METABOLISM; METAL TOXICITY; MOOD DISORDER; NEUROTOXICITY; NONHUMAN; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RESPIRATORY SYSTEM; REVIEW; SEX; CHEMICALLY INDUCED; GENETICS; METABOLISM; PSYCHOLOGY;

CATIONS, DIVALENT; HUMANS; MOOD DISORDERS; TRANSCRIPTION FACTORS;

EID: 84951963363     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2015.11.001     Document Type: Review

References (298)

1. Adhami V.M., Husain R., Husain R., Seth P.K. Influence of iron deficiency and lead treatment on behavior and cerebellar and hippocampal polyamine levels in neonatal rats. Neurochem. Res. 1996, 21:915-922.
2. Agostinho P., Duarte C.B., Carvalho A.P., Oliveira C.R. Effect of oxidative stress on the release of [3H]GABA in cultured chick retina cells. Brain Res. 1994, 655:213-221.
3. Ahamed M., Siddiqui M.K. Environmental lead toxicity and nutritional factors. Clin. Nutr. 2007, 26:400-408.
4. Al-Ayadhi L.Y. Heavy metals and trace elements in hair samples of autistic children in central Saudi Arabia. Neurosciences (Riyadh) 2005, 10:213-218.
5. Alsulimani H.A., Ye Q., Kim J. Effect of Hfe deficiency on memory capacity and motor coordination after manganese exposure by drinking water in mice. Toxicol. Res. 2015, In Press.
6. Anderson J.G., Cooney P.T., Erikson K.M. Brain manganese accumulation is inversely related to γ-amino butyric acid uptake in male and female rats. Toxicol. Sci. 2007, 95:188-195.
7. Anderson E.R., Taylor M., Xue X., Martin A., Moons D.S., et al. The hypoxia-inducible factor-C/EBPalpha axis controls ethanol-mediated hepcidin repression. Mol. Cell. Biol. 2012, 32:4068-4077.
8. Anderson D.W., Pothakos K., Schneider J.S. Sex and rearing condition modify the effects of perinatal lead exposure on learning and memory. Neurotoxicology 2012, 33:985-995.
9. Antonini J.M., Sriram K., Benkovic S.A., Roberts J.R., Stone S., et al. Mild steel welding fume causes manganese accumulation and subtle neuroinflammatory changes but not overt neuronal damage in discrete brain regions of rats after short-term inhalation exposure. Neurotoxicology 2009, 30:915-925.
10. Aposhian H.V., Maiorino R.M., Dart R.C., Perry D.F. Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects. Clin. Pharmacol. Ther. 1989, 45:520-526.
11. Arredondo M., Munoz P., Mura C.V., Nunez M.T. DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am. J. Physiol. Cell Physiol. 2003, 284:C1525-C1530.
12. Aschner M., Gannon M. Manganese (Mn) transport across the rat blood-brain barrier: saturable and transferrin-dependent transport mechanisms. Brain Res. Bull. 1994, 33:345-349.
13. Aschner M., Gannon M., Kimelberg H.K. Manganese uptake and efflux in cultured rat astrocytes. J. Neurochem. 1992, 58:730-735.
14. Aschner M., Guilarte T.R., Schneider J.S., Zheng W. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol. Appl. Pharmacol. 2007, 221:131-147.
15. Au C., Benedetto A., Aschner M. Manganese transport in eukaryotes: the role of DMT1. Neurotoxicology 2008, 29:569-576.
16. Bache C.A., Lisk D.J., Doss G.J., Hoffmann D., Adams J.D. Cadmium and nickel in mainstream particulates of cigarettes containing tobacco grown on a low-cadmium soil-sludge mixture. J. Toxicol. Environ. Health 1985, 16:547-552.
17. Bachman E., Feng R., Travison T., Li M., Olbina G., et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J. Clin. Endocrinol. Metab. 2010, 95:4743-4747.
18. Ballatori N. Transport of toxic metals by molecular mimicry. Environ. Health Perspect. 2002, 110:689-694.
19. I Bannon D., Portnoy M.E., Olivi L., Lees P.S., Culotta V.C., et al. Uptake of lead and iron by divalent metal transporter 1 in yeast and mammalian cells. Biochem. Biophys. Res. Commun. 2002, 295:978-984.
20. I Bannon D., Abounader R., Lees P.S.J., Bressler J.P. Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells 2003, C44-C50.
21. Barbeau A. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). Neurotoxicology 1984, 5:13-35.
22. Basha M.R., Wei W., Bakheet S.A., Benitez N., Siddiqi H.K., et al. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J. Neurosci. 2005, 25:823-829.
23. Beard J.L., Connor J.R. Iron status and neural functioning. Annu. Rev. Nutr. 2003, 23:41-58.
24. Benko C.R., Cordeiro M.L., Costa M.T., Cunha A., Farias A.C., et al. Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure. J. Child Adolesc. Psychopharmacol. 2010, 20:113.
25. Bertinchamps A.J., Miller S.T., Cotzias G.C. Interdependence of routes excreting manganese. Am. J. Physiol. 1966, 211:217-224.
26. Betharia S., Maher T.J. Neurobehavioral effects of lead and manganese individually and in combination in developmentally exposed rats. Neurotoxicology 2012, 33:1117-1127.
27. Bielarczyk H., Tomsig J.L., Suszkiw J.B. Perinatal low-level lead exposure and the septo-hippocampal cholinergic system: selective reduction of muscarinic receptors and cholineacetyltransferase in the rat septum. Brain Res. 1994, 643:211-217.
28. Blasco G., Puig J., Daunis I.E.J., Molina X., Xifra G., et al. Brain iron overload, insulin resistance, and cognitive performance in obese subjects: a preliminary MRI case-control study. Diabetes Care 2014, 37:3076-3083.
29. Blaurock-Busch E., Amin O.R., Rabah T. Heavy metals and trace elements in hair and urine of a sample of arab children with autistic spectrum disorder. Maedica (Buchar) 2011, 6:247-257.
30. Bock E., Weeke B., Rafaelsen O.J. Serum proteins in acutely psychotic patients. J. Psychiatr. Res. 1971, 9:1-9.
31. Bondier J.R., Michel G., Propper A., Badot P.M. Harmful effects of cadmium on olfactory system in mice. Inhal. Toxicol. 2008, 20:1169-1177.
32. Borras L., Huguelet P. Schizophrenia and beta-thalassemia: a genetic link?. Psychiatry Res. 2008, 158:260-261.
33. Bothwell T.H., Pribilla W.F., Mebust W., Finch C.A. Iron metabolism in the pregnant rabbit; iron transport across the placenta. Am. J. Physiol. 1958, 193:615-622.
34. Bouchard M., Laforest F., Vandelac L., Bellinger D., Mergler D. Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. Environ. Health Perspect. 2007, 115:122-127.
35. Bouchard M., Mergler D., Baldwin M.E., Panisset M. Manganese cumulative exposure and symptoms: a follow-up study of alloy workers. Neurotoxicology 2008, 29:577-583.
36. Bowler R.M., Gysens S., Diamond E., Nakagawa S., Drezgic M., et al. Manganese exposure: neuropsychological and neurological symptoms and effects in welders. Neurotoxicology 2006, 27:315-326.
37. Bradbury M.W. Transport of iron in the blood-brain-cerebrospinal fluid system. J. Neurochem. 1997, 69:443-454.
38. Bradman A., Eskenazi B., Sutton P., Athanasoulis M., Goldman L.R. Iron deficiency associated with higher blood lead in children living in contaminated environments. Environ. Health Perspect. 2001, 109:1079-1084.
39. Brain J.D., Heilig E., Donaghey T.C., Knutson M.D., Wessling-Resnick M., et al. Effects of iron status on transpulmonary transport and tissue distribution of Mn and Fe. Am. J. Respir. Cell. Mol. Biol. 2006, 34:330-337.
40. Braughler J.M. Lipid peroxidation-induced inhibition of gamma-aminobutyric acid uptake in rat brain synaptosomes: protection by glucocorticoids. J. Neurochem. 1985, 44:1282-1288.
41. Brenneman K.A., Wong B.A., Buccellato M.A., Costa E.R., Gross E.A., et al. Direct olfactory transport of inhaled manganese ((54)MnCl(2)) to the rat brain: toxicokinetic investigations in a unilateral nasal occlusion model. Toxicol. Appl. Pharmacol. 2000, 169:238-248.
42. Bressler J.P., Olivi L., Cheong J.H., Kim Y., Bannona D. Divalent metal transporter 1 in lead and cadmium transport. Ann. N. Y. Acad. Sci. 2004, 1012:142-152.
43. Brunk U.T., Svensson I. Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox. Rep. 1999, 4:3-11.
44. Buchet J.P., Lauwerys R., Roels H., Bernard A., Bruaux P., et al. Renal effects of cadmium body burden of the general population. Lancet 1990, 336:699-702.
45. Burdo J.R., Martin J., Menzies S.L., Dolan K.G., Romano M.A., et al. Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience 1999, 93:1189-1196.
46. Burdo J.R., Menzies S.L., Simpson I.A., Garrick L.M., Garrick M.D., et al. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 2001, 66:1198-1207.
47. Burdo J.R., Simpson I.A., Menzies S., Beard J., Connor J.R. Regulation of the profile of iron-management proteins in brain microvasculature. J. Cereb. Blood Flow Metab. 2004, 24:67-74.
48. Bush A.I. Metals and neuroscience. Curr. Opin. Chem. Biol. 2000, 4:184-191.
49. Bushnell P.J., Bowman R.E. Effects of chronic lead ingestion on social development in infant rhesus monkeys. Neurobehav. Toxicol. 1979, 1:207-219.
50. Centers for Disease Control and Prevention (CDC) Iron deficiency-United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2002, 51:897-899.
51. Candas D., Li J.J. MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx. Antioxid. Redox. Signal. 2014, 20:1599-1617.
52. Canonne-Hergaux F., Gros P. Expression of the iron transporter DMT1 in kidney from normal and anemic mk mice. Kidney Int. 2002, 62:147-156.
53. Canonne-Hergaux F., Levy J.E., Fleming M.D., Montross L.K., Andrews N.C., et al. Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disorders. Blood 2001, 97:1138-1140.
54. Canonne-Hergaux F., Zhang A.S., Ponka P., Gros P. Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mk mice. Blood 2001, 98:3823-3830.
55. Capel I.D., Pinnock M.H., Dorrell H.M., Williams D.C., Grant E.C. Comparison of concentrations of some trace, bulk, and toxic metals in the hair of normal and dyslexic children. Clin. Chem. 1981, 27:879-881.
56. Carlson E.S., Tkac I., Magid R., O'Connor M.B., Andrews N.C., et al. Iron is essential for neuron development and memory function in mouse hippocampus. J. Nutr. 2009, 139:672-679.
57. Chan P.H., Kerlan R., Fishman R.A. Reductions of gamma-aminobutyric acid and glutamate uptake and (Na++K+)-ATPase activity in brain slices and synaptosomes by arachidonic acid. J. Neurochem. 1983, 40:309-316.
58. Chandra S.V., Murthy R.C., Saxena D.K., Lal B. Effects of pre- and postnatal combined exposure to Pb and Mn on brain development in rats. Ind. Health 1983, 21:273-279.
59. Chang J., Kueon C., Kim J. Influence of lead on repetitive behavior and dopamine metabolism in a mouse model of iron overload. Toxicol. Res. 2014, 30:267-276.
60. Chen M.K., Lee J.S., McGlothan J.L., Furukawa E., Adams R.J., et al. Acute manganese administration alters dopamine transporter levels in the non-human primate striatum. Neurotoxicology 2006, 27:229-236.
61. Chen T., Li Y.Y., Zhang J.L., Xu B., Lin Y., et al. Protective effect of C(60)-methionine derivate on lead-exposed human SH-SY5Y neuroblastoma cells. J. Appl. Toxicol. 2011, 31:255-261.
62. Chen P., Chakraborty S., Mukhopadhyay S., Lee E., Paoliello M.M., et al. Manganese homeostasis in the nervous system. J. Neurochem. 2015, 134:601-610.
63. Cheong J.H., Bannon D., Olivi L., Kim Y., Bressler J. Different mechanisms mediate uptake of lead in a rat astroglial cell line. Toxicol. Sci. 2004, 77:334-340.
64. Chua A.C., Morgan E.H. Manganese metabolism is impaired in the Belgrade laboratory rat. J. Comp. Physiol. B 1997, 167:361-369.
65. Claus Henn B., Ettinger A.S., Schwartz J., Tellez-Rojo M.M., Lamadrid-Figueroa H., et al. Early postnatal blood manganese levels and children's neurodevelopment. Epidemiology 2010, 21:433-439.
66. Claus H., enn B., Kim J., Wessling-Resnick M., Téllez-Rojo M.M., Jayawardene I., et al. Associations of iron metabolism genes with blood manganese levels: a population-based study with validation data from animal models. Environ. Health 2011, 10:97.
67. Collipp P.J., Chen S.Y., Maitinsky S. Manganese in infant formulas and learning disability. Ann. Nutr. Metab. 1983, 27:488-494.
68. Colombo M., Hamelin C., Kouassi E., Fournier M., Bernier J. Differential effects of mercury, lead, and cadmium on IL-2 production by Jurkat T cells. Clin. Immunol. 2004, 111:311-322.
69. Connor J.R., Menzies S.L. Relationship of iron to oligodendrocytes and myelination. Glia 1996, 17:83-93.
70. Cory-Slechta D.A. Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity. Neurotoxicology 1997, 18:673-688.
71. Cotzias G.C. Manganese in health and disease. Physiol. Rev. 1958, 38:503-532.
72. Coyle J.T. The GABA-glutamate connection in schizophrenia: which is the proximate cause?. Biochem. Pharmacol. 2004, 68:1507-1514.
73. Crapo J.D., Oury T., Rabouille C., Slot J.W., Chang L.Y. Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:10405-10409.
74. Crapper McLachlan D.R., Dalton A.J., Kruck T.P., Bell M.Y., Smith W.L., et al. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 1991, 337:1304-1308.
75. Crossgrove J.S., Yokel R.A. Manganese distribution across the blood-brain barrier III: The divalent metal transporter-1 is not the major mechanism mediating brain manganese uptake. Neurotoxicology 2004, 25:451-460.
76. Crowe A., Morgan E.H. Interactions between tissue uptake of lead and iron in normal and iron-deficient rats during development. Biol. Trace Elem. Res. 1996, 52:249-261.
77. Crownover B.K., Covey C.J. Hereditary hemochromatosis. Am. Fam. Phys. 2013, 87:183-190.
78. Dabrowska-Bouta B., Sulkowski G., Walski M., Struzynska L., Lenkiewicz A., et al. Acute lead intoxication in vivo affects myelin membrane morphology and CNPase activity. Exp. Toxicol. Pathol. 2000, 52:257-263.
79. Dingwall-Fordyce I., Lane R.E. A follow-up study of lead workers. Br. J. Ind. Med. 1963, 20:313-315.
80. Dobson A.W., Erikson K.M., Aschner M. Manganese neurotoxicity. Ann. N. Y. Acad. Sci. 2004, 1012:115-128.
81. Dodd C.A., Filipov N.M. Manganese potentiates lps-induced heme-oxygenase 1 in microglia but not dopaminergic cells: role in controlling microglial hydrogen peroxide and inflammatory cytokine output. Neurotoxicology 2011, 32:683-692.
82. Donaldson J. The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 1987, 8:451-462.
83. Elseweidy M.M., Abd El-Baky A.E. Effect of dietary iron overload in rat brain: oxidative stress, neurotransmitter level and serum metal ion in relation to neurodegenerative disorders. Indian J. Exp. Biol. 2008, 46:855-858.
84. Ericson J.E., Crinella F.M., Clarke-Stewart K.A., Allhusen V.D., Chan T., et al. Prenatal manganese levels linked to childhood behavioral disinhibition. Neurotoxicol. Teratol. 2007, 29:181-187.
85. Erikson K., Aschner M. Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology 2002, 23:595-602.
86. Erikson K.M., Aschner M. Manganese neurotoxicity and glutamate-GABA interaction. Neurochem. Int. 2003, 43:475-480.
87. Erikson K.M., Aschner M. Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicology 2006, 27:125-130.
88. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411:342-348.
89. Farcich E.A., Morgan E.H. Uptake of transferrin-bound and nontransferrin-bound iron by reticulocytes from the Belgrade laboratory rat: comparison with Wistar rat transferrin and reticulocytes. Am. J. Hematol. 1992, 39:9-14.
90. Ferguson C.J., Wareing M., Delannoy M., Fenton R., McLarnon S.J., et al. Iron handling and gene expression of the divalent metal transporter, DMT1, in the kidney of the anemic Belgrade (b) rat. Kidney Int. 2003, 64:1755-1764.
91. Fine J.M., Baillargeon A.M., Renner D.B., Hoerster N.S., Tokarev J., et al. Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice. Exp. Brain Res. 2012, 219:381-390.
92. Finkelstein Y., Markowitz M.E., Rosen J.F. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res. Brain Res. Rev. 1998, 27:168-176.
93. Finkelstein Y., Milatovic D., Aschner M. Modulation of cholinergic systems by manganese. Neurotoxicology 2007, 28:1003-1014.
94. Flanagan P.R., Haist J., Valberg L.S. Comparative effects of iron deficiency induced by bleeding and a low-iron diet on the intestinal absorptive interactions of iron, cobalt, manganese, zinc, lead and cadmium. J. Nutr. 1980, 110:1754-1763.
95. Fleming M.D., Trenor 3rd C.C., Su M.A., Foernzler D., Beier D.R., et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 1997, 16:383-386.
96. Fleming M.D., Romano M.A., Su M.A., Garrick L.M., Garrick M.D., et al. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:1148-1153.
97. Flynn J.M., Melov S. SOD2 in mitochondrial dysfunction and neurodegeneration. Free Radic. Biol. Med. 2013, 62:4-12.
98. Freret T., Valable S., Chazalviel L., Saulnier R., Mackenzie E.T., et al. Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. Eur. J. Neurosci. 2006, 23:1757-1765.
99. Fry R.C., Navasumrit P., Valiathan C., Svensson J.P., Hogan B.J., et al. Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 2007, 3:e207.
100. Gadhia S.R., Calabro A.R., Barile F.A. Trace metals alter DNA repair and histone modification pathways concurrently in mouse embryonic stem cells. Toxicol. Lett. 2012, 212:169-179.
101. Garcia S.J., Gellein K., Syversen T., Aschner M. A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol. Sci 2006, 92:516-525.
102. Garrick M.D., Dolan K.G., Horbinski C., Ghio A.J., Higgins D., et al. DMT1: a mammalian transporter for multiple metals. Biometals 2003, 16:41-54.
103. Garrick M.D., Singleton S.T., Vargas F., Kuo H.C., Zhao L., et al. DMT1: which metals does it transport?. Biol. Res. 2006, 39:79-85.
104. Ghio A.J., Piantadosi C.A., Wang X., Dailey L.A., Stonehuerner J.D., et al. Divalent metal transporter-1 decreases metal-related injury in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L460-L467.
105. Ghio A.J., Turi J.L., Madden M.C., Dailey L.A., Richards J.D., et al. Lung injury after ozone exposure is iron dependent. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L134-L143.
106. Glausier J.R., Kimoto S., Fish K.N., Lewis D.A. Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia. Biol. Psychiatry 2015, 77:167-176.
107. Glei M., Latunde-Dada G.O., Klinder A., Becker T.W., Hermann U., et al. Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A. Mutat. Res. 2002, 519:151-161.
108. Gonçalves J.F., Fiorenza A.M., Spanevello R.M., Mazzanti C.M., Bochi G.V., et al. N-acetylcysteine prevents memory deficits, the decrease in acetylcholinesterase activity and oxidative stress in rats exposed to cadmium. Chem. Biol. Interact. 2010, 186:53-60.
109. Gonzalez-Reyes R.E., Gutierrez-Alvarez A.M., Moreno C.B. Manganese and epilepsy: a systematic review of the literature. Brain Res. Rev. 2007, 53:332-336.
110. Grant J.E., Odlaug B.L., Kim S.W. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch. Gen. Psychiatry 2009, 66:756-763.
111. Gu C., Chen S., Xu X., Zheng L., Li Y., et al. Lead and cadmium synergistically enhance the expression of divalent metal transporter 1 protein in central nervous system of developing rats. Neurochem. Res. 2009, 34:1150-1156.
112. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388:482-488.
113. Gunshin H., Fujiwara Y., Custodio A.O., DiRenzo C., Robine S., et al. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J. Clin. Invest. 2005, 115:1258-1266.
114. Guo W., Bachman E., Li M., Roy C.N., Blusztajn J., et al. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell 2013, 12:280-291.
115. Gupta A., Murthy R.C., Thakur S.R., Dubey M.P., Chandra S.V. Comparative neurotoxicity of cadmium in growing and adult rats after repeated administration. Biochem. Int. 1990, 21:97-105.
116. Harrison-Findik D.D., Schafer D., Klein E., Timchenko N.A., Kulaksiz H., et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J. Biol. Chem. 2006, 281:22974-22982.
117. He Q., Du T., Yu X., Xie A., Song N., et al. DMT1 polymorphism and risk of Parkinson's disease. Neurosci. Lett. 2011, 501:128-131.
118. Heilig E.A., Thompson K.J., Molina R.M., Ivanov A.R., Brain J.D., et al. Manganese and iron transport across pulmonary epithelium. Am J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L1247-L1259.
119. Henriksson J., Tjalve H. Manganese taken up into the CNS via the olfactory pathway in rats affects astrocytes. Toxicol. Sci. 2000, 55:392-398.
120. Henson M.C., Chedrese P.J. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp. Biol. Med. (Maywood) 2004, 229:383-392.
121. Hermes-Lima M., Pereira B., Bechara E.J. Are free radicals involved in lead poisoning?. Xenobiotica 1991, 21:1085-1090.
122. Honda K., Casadesus G., Petersen R.B., Perry G., Smith M.A. Oxidative stress and redox-active iron in Alzheimer's disease. Ann. N. Y. Acad. Sci. 2004, 1012:179-182.
123. Hong S.B., Kim J.W., Choi B.S., Hong Y.C., Park E.J., et al. Blood manganese levels in relation to comorbid behavioral and emotional problems in children with attention-deficit/hyperactivity disorder. Psychiatry Res. 2014, 220:418-425.
124. Horning K.J., Caito S.W., Tipps K.G., Bowman A.B., Aschner M. Manganese is essential for neuronal health. Annu. Rev. Nutr. 2015, 35:71-108.
125. Hu H., Shine J., Wright R.O. The challenge posed to children's health by mixtures of toxic waste: the Tar Creek superfund site as a case-study. Pediatr. Clin. North Am. 2007, 54:155-175.
126. Hu F., Xu L., Liu Z.-H., Ge M.-M., Ruan D.-Y., et al. Developmental lead exposure alters synaptogenesis through inhibiting canonical wnt pathway in vivo and in vitro. PLoS One 2014, 9:e101894.
127. Hua Y., Nakamura T., Keep R.F., Wu J., Schallert T., et al. Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg 2006, 104:305-312.
128. Huang C.C., Lu C.S., Chu N.S., Hochberg F., Lilienfeld D., et al. Progression after chronic manganese exposure. Neurology 1993, 43:1479.
129. Hurley L.S., Woolley D.E., Rosenthal F., Timiras P.S. Influence of manganese on susceptibility of rats to convulsions. Am. J. Physiol. 1963, 204:493-496.
130. Ikeda Y., Tajima S., Izawa-Ishizawa Y., Kihira Y., Ishizawa K., et al. Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes. PLoS One 2012, 7:e40465.
131. Illing A.C., Shawki A., Cunningham C.L., Mackenzie B. Substrate profile and metal-ion selectivity of human divalent metal-ion transporter-1. J. Biol. Chem. 2012, 287:30485-30496.
132. Ishitobi H., Watanabe C. Effects of low-dose perinatal cadmium exposure on tissue zinc and copper concentrations in neonatal mice and on the reproductive development of female offspring. Toxicol. Lett. 2005, 159:38-46.
133. Jiang L., Garrick M.D., Garrick L.M., Zhao L., Collins J.F. Divalent metal transporter 1 (Dmt1) mediates copper transport in the duodenum of iron-deficient rats and when overexpressed in iron-deprived HEK-293 cells. J. Nutr. 2013, 143:1927-1933.
134. Johnson S.R., Winkleby M.A., Boyce W.T., McLaughlin R., Broadwin R., et al. The association between hemoglobin and behavior problems in a sample of low-income Hispanic preschool children. J. Dev. Behav. Pediatr. 1992, 13:209-214.
135. Johnstone D.M., Graham R.M., Trinder D., Riveros C., Olynyk J.K., et al. Changes in brain transcripts related to Alzheimer's disease in a model of HFE hemochromatosis are not consistent with increased Alzheimer's disease risk. J. Alzheimers Dis. 2012, 30:791-803.
136. Jomova K., Vondrakova D., Lawson M., Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 2010, 345:91-104.
137. Karver C.L., Wade S.L., Cassedy A., Taylor H.G., Stancin T., et al. Age at injury and long-term behavior problems after traumatic brain injury in young children. Rehabil. Psychol. 2012, 57:256-265.
138. Kasten-Jolly J., Pabello N., Bolivar V.J., Lawrence D.A. Developmental lead effects on behavior and brain gene expression in male and female BALB/cAnNTac mice. Neurotoxicology 2012, 33:1005-1020.
139. Ke Y., Qian Z.M. Brain iron metabolism: neurobiology and neurochemistry. Prog. Neurobiol. 2007, 83:149-173.
140. Kern C.H., Smith D.R. Preweaning Mn exposure leads to prolonged astrocyte activation and lasting effects on the dopaminergic system in adult male rats. Synapse 2011, 65:532-544.
141. Kern C., Stanwood G., Smith D.R. Pre-weaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels. Synapse (New York, NY) 2010, 64:363-378.
142. Kerper L.E., Hinkle P.M. Lead uptake in brain capillary endothelial cells: activation by calcium store depletion. Toxicol. Appl. Pharmacol. 1997, 146:127-133.
143. Kerper L.E., Hinkle P.M. Cellular uptake of lead is activated by depletion of intracellular calcium stores. J. Biol. Chem. 1997, 272:8346-8352.
144. Khan K., Factor-Litvak P., Wasserman G.A., Liu X., Ahmed E., et al. Manganese exposure from drinking water and children's classroom behavior in Bangladesh. Environ. Health Perspect. 2011, 119:1501-1506.
145. Kim J., Wessling-Resnick M. Iron and mechanisms of emotional behavior. J. Nutr. Biochem. 2014, 25:1101-1107.
146. Kim Y., Kim J.M., Kim J.W., Yoo C.I., Lee C.R., et al. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?. Mov. Disord. 2002, 17:568-575.
147. Kim J., Molina R.M., Donaghey T.C., Buckett P.D., Brain J.D., et al. Influence of DMT1 and iron status on inflammatory responses in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300:L659-L665.
148. Kim J., Li Y., Buckett P.D., Bohlke M., Thompson K.J., et al. Iron-responsive olfactory uptake of manganese improves motor function deficits associated with iron deficiency. PLoS One 2012, 7:e33533.
149. Kim J., Jia X., Buckett P.D., Liu S., Lee C.H., et al. Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia. FASEB J. 2013, 27:1657-1663.
150. Kim J., Buckett P.D., Wessling-Resnick M. Absorption of manganese and iron in a mouse model of hemochromatosis. PLoS One 2013, 8:e64944.
151. Kimoto S., Bazmi H.H., Lewis D.A. Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am. J. Psychiatry 2014, 171:969-978.
152. Klebe D., Krafft P.R., Hoffmann C., Lekic T., Flores J.J., et al. Acute and delayed deferoxamine treatment attenuates long-term sequelae after germinal matrix hemorrhage in neonatal rats. Stroke 2014, 45:2475-2479.
153. Knopfel M., Zhao L., Garrick M.D. Transport of divalent transition-metal ions is lost in small-intestinal tissue of b/b Belgrade rats. Biochemistry 2005, 44:3454-3465.
154. Kushner J.P., Porter J.P., Olivieri N.F. Secondary iron overload. Hematol. Am. Soc. Hematol. Educ. Prog. 2001, 47-61.
155. López E., Arce C., Oset-Gasque M.J., Cañadas S., González M.P. Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. Free Radic. Biol. Med. 2006, 40:940-951.
156. Lafuente A., Esquifino A.I. Cadmium effects on hypothalamic activity and pituitary hormone secretion in the male. Toxicol. Lett. 1999, 110:209-218.
157. Lafuente A., Gonzalez-Carracedo A., Romero A., Esquifino A.I. Effect of cadmium on 24-h variations in hypothalamic dopamine and serotonin metabolism in adult male rats. Exp. Brain Res. 2003, 149:200-206.
158. Lan J., Jiang D.H. Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice. J. Neural Transm. 1997, 104:469-481.
159. Landrigan P.J., Baker E.L., Feldman R.G., Cox D.H., Eden K.V., et al. Increased lead absorption with anemia and slowed nerve conduction in children near a lead smelter. J. Pediatr. 1976, 89:904-910.
160. Lavoie S., Murray M.M., Deppen P., Knyazeva M.G., Berk M., et al. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology 2008, 33:2187-2199.
161. Legare M.E., Barhoumi R., Hebert E., Bratton G.R., Burghardt R.C., et al. Analysis of Pb2+ entry into cultured astroglia. Toxicol. Sci. 1998, 46:90-100.
162. Lehotzky K., Ungvary G., Polinak D., Kiss A. Behavioral deficits due to prenatal exposure to cadmium chloride in CFY rat pups. Neurotoxicol. Teratol. 1990, 12:169-172.
163. Levin R., Brown M.J., Kashtock M.E., Jacobs D.E., Whelan E.A., et al. Lead exposures in U.S. Children, 2008: implications for prevention. Environ. Health Perspect. 2008, 116:1285-1293.
164. Levy J.E., Montross L.K., Cohen D.E., Fleming M.D., Andrews N.C. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood 1999, 94:9-11.
165. Levy J.E., Montross L.K., Andrews N.C. Genes that modify the hemochromatosis phenotype in mice. J. Clin. Invest. 2000, 105:1209-1216.
166. Leyva-Illades D., Chen P., Zogzas C.E., Hutchens S., Mercado J.M. SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity 2014, 34:14079-14095.
167. Li G.J., Choi B.S., Wang X., Liu J., Waalkes M.P., et al. Molecular mechanism of distorted iron regulation in the blood-CSF barrier and regional blood-brain barrier following in vivo subchronic manganese exposure. Neurotoxicology 2006, 27:737-744.
168. Li Y.Y., Chen T., Wan Y., Xu S.Q. Lead exposure in pheochromocytoma cells induces persistent changes in amyloid precursor protein gene methylation patterns. Environ. Toxicol. 2012, 27:495-502.
169. Liu X., Sullivan K.A., Madl J.E., Legare M., Tjalkens R.B. Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration. Toxicol. Sci. 2006, 91:521-531.
170. Lozoff B. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J. Nutr. 2011, 141:740S-746S.
171. Lucchini R., Apostoli P., Perrone C., Placidi D., Albini E., et al. Long-term exposure to low levels of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology 1999, 20:287-297.
172. Maaroufi K., Ammari M., Jeljeli M., Roy V., Sakly M., et al. Impairment of emotional behavior and spatial learning in adult Wistar rats by ferrous sulfate. Physiol. Behav. 2009, 96:343-349.
173. Madejczyk M.S., Ballatori N. The iron transporter ferroportin can also function as a manganese exporter. Biochim. Biophys. Acta 2012, 1818:651-657.
174. Markesbery W.R., Ehmann W.D., Alauddin M., Hossain T.I. Brain trace element concentrations in aging. Neurobiol. Aging 1984, 5:19-28.
175. Markovac J., Goldstein G.W. Picomolar concentrations of lead stimulate brain protein kinase C. Nature 1988, 334:71-73.
176. Marlowe M., Errera J., Jacobs J. Increased lead and cadmium burdens among mentally retarded children and children with borderline intelligence. Am. J. Ment. Defic. 1983, 87:477-483.
177. Martinez A., Knappskog P.M., Haavik J. A structural approach into human tryptophan hydroxylase and its implications for the regulation of serotonin biosynthesis. Curr. Med. Chem. 2001, 8:1077-1091.
178. Martinez-Finley E.J., Gavin C.E., Aschner M., Gunter T.E. Manganese neurotoxicity and the role of reactive oxygen species. Free Radic. Biol. Med. 2013, 62:65-75.
179. Mason L.H., Harp J.P., Han D.Y. Pb neurotoxicity: neuropsychological effects of lead toxicity. BioMed Res. Int. 2014, 2014(8).
180. Massie H.R., Aiello V.R., Iodice A.A. Changes with age in copper and superoxide dismutase levels in brains of C57BL/6J mice. Mech. Ageing Dev. 1979, 10:93-99.
181. Mateo R., Beyer W.N., Spann J.W., Hoffman D.J., Ramis A. Relationship between oxidative stress, pathology, and behavioral signs of lead poisoning in mallards. J. Toxicol. Environ. Health A 2003, 66:1371-1389.
182. Mendelsohn A.L., Dreyer B.P., Fierman A.H., Rosen C.M., Legano L.A., et al. Low-level lead exposure and behavior in early childhood. Pediatrics 1998, 101:E10.
183. Menezes-Filho J.A., de Carvalho-Vivas C.F., Viana G.F., Ferreira J.R., Nunes L.S., et al. Elevated manganese exposure and school-aged children's behavior: a gender-stratified analysis. Neurotoxicology 2014, 45:293-300.
184. Mergler D., Baldwin M., Belanger S., Larribe F., Beuter A., et al. Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology 1999, 20:327-342.
185. Meyer P.A., Brown M.J., Falk H. Global approach to reducing lead exposure and poisoning. Mutat. Res. 2008, 659:166-175.
186. Milatovic D., Yin Z., Gupta R.C., Sidoryk M., Albrecht J., et al. Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol. Sci. 2007, 98:198-205.
187. Miller D.K., Nation J.R. Chronic cadmium exposure attenuates the conditioned reinforcing properties of morphine and fentanyl. Brain Res. 1997, 776:162-169.
188. Milman A., Rosenberg A., Weizman R., Pick C.G. Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J. Neurotrauma 2005, 22:1003-1010.
189. Molina R.M., Phattanarudee S., Kim J., Thompson K., Wessling-Resnick M., et al. Ingestion of Mn and Pb by rats during and after pregnancy alters iron metabolism and behavior in offspring. Neurotoxicology 2011, 32:413-422.
190. Montosi G., Donovan A., Totaro A., Garuti C., Pignatti E., et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 2001, 108:619-623.
191. Morello M., Canini A., Mattioli P., Sorge R.P., Alimonti A., et al. Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. Neurotoxicology 2008, 29:60-72.
192. Moreno J.A., Streifel K.M., Sullivan K.A., Legare M.E., Tjalkens R.B. Developmental exposure to manganese increases adult susceptibility to inflammatory activation of glia and neuronal protein nitration. Toxicol. Sci. 2009, 112:405-415.
193. Muwakkit S., Nuwayhid I., Nabulsi M., al Hajj R., Khoury R., et al. Iron deficiency in young Lebanese children: association with elevated blood lead levels. J. Pediatr. Hematol. Oncol. 2008, 30:382-386.
194. Nagatsu T. Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology. Essays Biochem. 1995, 30:15-35.
195. Nam H., Wang C.-Y., Zhang L., Zhang W., Hojyo S., et al. ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders. Haematologica 2013, 98:1049-1057.
196. Nandar W., Neely E.B., Unger E., Connor J.R. A mutation in the HFE gene is associated with altered brain iron profiles and increased oxidative stress in mice. Biochim. Biophys. Acta 2013, 1832:729-741.
197. Nation J.R., Baker D.M., Taylor B., Clark D.E. Dietary lead increases ethanol consumption in the rat. Behav. Neurosci. 1986, 100:525-530.
198. Nation J.R., Pugh C.K., Von S., tultz J., Bratton G.R., Clark D.E. The effects of cadmium on the self-administration of ethanol and an isocaloric/isohedonic equivalent. Neurotoxicol. Teratol. 1989, 11:509-514.
199. Nation J.R., Livermore C.L., Bratton G.R., Schenk S. Chronic cadmium exposure alters cocaine self-administration in adult male rats. Exp. Clin. Psychopharmacol. 1996, 4:264-270.
200. Needleman H.L., Riess J.A., Tobin M.J., Biesecker G.E., Greenhouse J.B. Bone lead levels and delinquent behavior. JAMA 1996, 275:363-369.
201. Needleman H. Lead poisoning. Annu. Rev. Med. 2004, 55:209-222.
202. Nielsen J.E., Jensen L.N., Krabbe K. Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome. J. Neurol. Neurosurg. Psychiatry 1995, 59:318-321.
203. Ohrvik H., Tyden E., Artursson P., Oskarsson A., Tallkvist J. Cadmium transport in a model of neonatal intestinal cells correlates to MRP1 and Not DMT1 or FPN1. ISRN Toxicol. 2013, 2013:892364.
204. Ohtake T., Saito H., Hosoki Y., Inoue M., Miyoshi S., et al. Hepcidin is down-regulated in alcohol loading. Alcohol. Clin. Exp. Res. 2007, 31:S2-S8.
205. Oliveira C.R., Agostinho P., Caseiro P., Duarte C.B., Carvalho A.P. Reactive oxygen species on GABA release. Ann. N. Y. Acad. Sci. 1994, 738:130-140.
206. Pagano G., Talamanca A.A., Castello G., Cordero M.D., d'Ischia M., et al. Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies. Oxid. Med. Cell. Longev. 2014, 2014:541230.
207. Palmeira C.M., Santos M.S., Carvalho A.P., Oliveira C.R. Membrane lipid peroxidation induces changes in gamma-[3H]aminobutyric acid transport and calcium uptake by synaptosomes. Brain Res. 1993, 609:117-123.
208. Park C., Park S.K. Molecular links between mitochondrial dysfunctions and schizophrenia. Mol. Cells 2012, 33:105-110.
209. Park J.D., Cherrington N.J., Klaassen C.D. Intestinal absorption of cadmium is associated with divalent metal transporter 1 in Rats. Toxicol. Sci. 2002, 68:288-294.
210. Pelizzoni I., Zacchetti D., Smith C.P., Grohovaz F., Codazzi F. Expression of divalent metal transporter 1 in primary hippocampal neurons: reconsidering its role in non-transferrin-bound iron influx. J. Neurochem. 2012, 120:269-278.
211. Pelizzoni I., Zacchetti D., Campanella A., Grohovaz F., Codazzi F. Iron uptake in quiescent and inflammation-activated astrocytes: a potentially neuroprotective control of iron burden. Biochim. Biophys. Acta 2013, 1832:1326-1333.
212. Pesch B., Haerting J., Ranft U., Klimpel A., Oelschlagel B., et al. Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter urothelial and renal cancer study. Int. J. Epidemiol. 2000, 29:1014-1024.
213. Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N. Engl. J. Med. 2004, 350:2383-2397.
214. Pisansky M.T., Wickham R.J., Su J., Fretham S., Yuan L.-L., et al. Iron deficiency with or without anemia impairs prepulse inhibition of the startle reflex. Hippocampus 2013, 23:952-962.
215. Prabhakaran K., Ghosh D., Chapman G.D., Gunasekar P.G. Molecular mechanism of manganese exposure-induced dopaminergic toxicity. Brain Res. Bull. 2008, 76:361-367.
216. Qian Z.M., Wu X.M., Fan M., Yang L., Du F., et al. Divalent metal transporter 1 is a hypoxia-inducible gene. J. Cell. Physiol. 2011, 226:1596-1603.
217. Rao T.S.S., Asha M.R., Ramesh B.N., Rao K.S.J. Understanding nutrition, depression and mental illnesses. Indian J. Psychiatry 2008, 50:77-82.
218. Raz E., Jensen J.H., Ge Y., Babb J.S., Miles L., et al. Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study. AJNR Am. J. Neuroradiol. 2011, 32:1851-1856.
219. Rodriguez-Rodriguez A., Egea-Guerrero J.J., Murillo-Cabezas F., Carrillo-Vico A. Oxidative stress in traumatic brain injury. Curr. Med. Chem. 2014, 21:1201-1211.
220. Roling J.A., Bain L.J., Gardea-Torresdey J., Bader J., Baldwin W.S. Hexavalent chromium reduces larval growth and alters gene expression in mummichog (Fundulus heteroclitus). Environ. Toxicol. Chem. 2006, 25:2725-2733.
221. Rosas H.D., Chen Y.I., Doros G., Salat D.H., Chen N.K., et al. Alterations in brain transition metals in Huntington disease: an evolving and intricate story. Arch. Neurol. 2012, 69:887-893.
222. Rossander-Hulten L., Brune M., Sandstrom B., Lonnerdal B., Hallberg L. Competitive inhibition of iron absorption by manganese and zinc in humans. Am. J. Clin. Nutr. 1991, 54:152-156.
223. Roy A., Bellinger D., Hu H., Schwartz J., Ettinger A.S., et al. Lead exposure and behavior among young children in Chennai, India. Environ. Health Perspect. 2009, 117:1607-1611.
224. Ruivard M., Laine F., Ganz T., Olbina G., Westerman M., et al. Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. J. Hepatol. 2009, 50:1219-1225.
225. Ryu D.-Y., Lee S.-J., Park D.W., Choi B.-S., Klaassen C.D., et al. Dietary iron regulates intestinal cadmium absorption through iron transporters in rats. Toxicol. Lett. 2004, 152:19-25.
226. Salvador G.A., Uranga R.M., Giusto N.M. Iron and mechanisms of neurotoxicity. Int. J. Alzheimers Dis. 2010, 2011:720658.
227. Sassine M.-P., Mergler D., Bowler R., Hudnell H.K. Manganese accentuates adverse mental health effects associated with alcohol use disorders. Biol. Psychiatry 2002, 51:909-921.
228. Schipper H.M. Neurodegeneration with brain iron accumulation-clinical syndromes and neuroimaging. Biochimica. et Biophysica. Acta (BBA) - Mol. Basis Dis. 2012, 1822:350-360.
229. Schmidt M.J., Mirnics K.N. Neurodevelopment, GABA system dysfunction, and schizophrenia. Neuropsychopharmacology 2015, 40:190-206.
230. Schroeder H.A. Cadmium hypertension in rats. Am. J. Physiol. 1964, 207:62-66.
231. Schumann K., Elsenhans B., Ehtechami C., Forth W. Increased intestinal iron absorption in rats with normal hepatic iron stores. Kinetic aspects of the adaptative response to parenteral iron repletion in dietary iron deficiency. Biochim. Biophys. Acta 1990, 1033:277-281.
232. Schwartz B.S., Stewart W.F., Bolla K.I., Simon P.D., Bandeen-Roche K., et al. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology 2000, 55:1144-1150.
233. Schwarzbold M., Diaz A., Martins E.T., Rufino A., Amante L.N., et al. Psychiatric disorders and traumatic brain injury. Neuropsychiatr. Dis. Treat. 2008, 4:797-816.
234. Sciarillo W.G., Alexander G., Farrell K.P. Lead exposure and child behavior. Am. J. Public Health 1992, 82:1356-1360.
235. Shaw G.C., Cope J.J., Li L., Corson K., Hersey C., et al. Mitoferrin is essential for erythroid iron assimilation. Nature 2006, 440:96-100.
236. Shiota A., Hiramatsu M., Mori A. Amino acid neurotransmitters in iron-induced epileptic foci of rats. Res. Commun. Chem. Pathol. Pharmacol. 1989, 66:123-133.
237. Shukla A., Shukla G.S., Srimal R.C. Cadmium-induced alterations in blood-brain barrier permeability and its possible correlation with decreased microvessel antioxidant potential in rat. Hum. Exp. Toxicol. 1996, 15:400-405.
238. Siddappa A.J., Rao R.B., Wobken J.D., Leibold E.A., Connor J.R., et al. Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain. J. Neurosci. Res. 2002, 68:761-775.
239. Siddappa A.J., Rao R.B., Wobken J.D., Casperson K., Leibold E.A., et al. Iron deficiency alters iron regulatory protein and iron transport protein expression in the perinatal rat brain. Pediatr. Res. 2003, 53:800-807.
240. Siedlak S.L., Casadesus G., Webber K.M., Pappolla M.A., Atwood C.S., et al. Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease. Free Radic. Res. 2009, 43:156-164.
241. Siimes M.A., Addiego J.E., Dallman P.R. Ferritin in serum: diagnosis of iron deficiency and iron overload in infants and children. Blood 1974, 43:581-590.
242. Sobotka T.J., Whittaker P., Sobotka J.M., Brodie R.E., Wander D.Y., et al. Neurobehavioral dysfunctions associated with dietary iron overload. Physiol. Beh. 1996, 59:213-219.
243. Sripetchwandee J., Pipatpiboon N., Chattipakorn N., Chattipakorn S. Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity. PLoS One 2014, 9:e85115.
244. Steinberg K.K., Cogswell M.E., Chang J.C., Caudill S.P., McQuillan G.M., et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001, 285:2216-2222.
245. Steinhauser S., Heinz U., Bartholomä M., Weyhermüller T., Nick H., et al. Complex formation of ICL670 and related ligands with FeIII and FeII. Eur. J. Inorg. Chem. 2004, 2004:4177-4192.
246. Strause L.G., Hegenauer J., Saltman P., Cone R., Resnick D. Effects of long-term dietary manganese and copper deficiency on rat skeleton. J. Nutr. 1986, 116:135-141.
247. Struzynska L., Walski M., Gadamski R., Dabrowska-Bouta B., Rafalowska U. Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. Mol. Chem. Neuropathol. 1997, 31:207-224.
248. Swaiman K.F., Machen V.L. The effect of iron on mammalian cortical neurons in culture. Neurochem. Res. 1985, 10:1261-1268.
249. Tabuchi M., Yoshimori T., Yamaguchi K., Yoshida T., Kishi F. Human NRAMP2/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in HEp-2Cells. J. Biol. Chem. 2000, 275:22220-22228.
250. Takser L., Mergler D., Hellier G., Sahuquillo J., Huel G. Manganese, monoamine metabolite levels at birth, and child psychomotor development. Neurotoxicology 2003, 24:667-674.
251. Tallkvist J., Bowlus C.L., Lonnerdal B. DMT1 gene expression and cadmium absorption in human absorptive enterocytes. Toxicol. Lett. 2001, 122:171-177.
252. Tavakoli-Nezhad M., Barron A.J., Pitts D.K. Postnatal inorganic lead exposure decreases the number of spontaneously active midbrain dopamine neurons in the rat. Neurotoxicology 2001, 22:259-269.
253. Taylor P.N., Patterson H.H., Klimis-Tavantzis D.J. Manganese deficiency alters high-density lipoprotein subclass structure in the sprague-dawley rat. J. Nutr. Biochem. 1996, 7:392-396.
254. Tchounwou P.B., Yedjou C.G., Patlolla A.K., Sutton D.J. Heavy metals toxicity and the environment. EXS 2012, 101:133-164.
255. Thatcher R.W., McAlaster R., Lester M.L. Evoked potentials related to hair cadmium and lead in children. Ann. N. Y. Acad. Sci. 1984, 425:384-390.
256. Thompson K., Molina R.M., Brain J.D., Wessling-Resnick M. Belgrade rats display liver iron loading. J. Nutr. 2006, 136:3010-3014.
257. Thompson K., Molina R., Donaghey T., Brain J.D., Wessling-Resnick M. The influence of high iron diet on rat lung manganese absorption. Toxicol. Appl. Pharmacol. 2006, 210:17-23.
258. Thompson K., Molina R.M., Donaghey T., Schwob J.E., Brain J.D., et al. Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB J. 2007, 21:223-230.
259. Tobwala S., Wang H.-J., Carey J., Banks W., Ercal N. Effects of lead and cadmium on brain endothelial cell survival, monolayer permeability, and crucial oxidative stress markers in an in vitro model of the blood-brain barrier. Toxics 2014, 2:258.
260. Toscano C.D., Guilarte T.R. Lead neurotoxicity: from exposure to molecular effects. Brain Res. Brain Res. Rev. 2005, 49:529-554.
261. Tran T.T., Chowanadisai W., Lönnerdal B., Le L., Parker M., et al. Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive functions. Neurotoxicology 2002, 23:645-651.
262. Trinder D., Oates P.S., Thomas C., Sadleir J., Morgan E.H. Localisation of divalent metal transporter 1 (DMT1) to the microvillus membrane of rat duodenal enterocytes in iron deficiency, but to hepatocytes in iron overload. Gut 2000, 46:270-276.
263. Urani C., Melchioretto P., Fabbri M., Bowe G., Maserati E., et al. Cadmium Impairs p53 activity in HepG2 Cells. ISRN Toxicol. 2014, 2014:976428.
264. Urrutia P., Aguirre P., Esparza A., Tapia V., Mena N.P., et al. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J. Neurochem. 2013, 126:541-549.
265. Valko M., Morris H., Cronin M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12:1161-1208.
266. Vazquez M., Velez D., Devesa V., Puig S. Participation of divalent cation transporter DMT1 in the uptake of inorganic mercury. Toxicology 2015, 331:119-124.
267. Vergani L., Cristina L., Paola R., Luisa A.M., Shyti G., et al. Metals, metallothioneins and oxidative stress in blood of autistic children. Res. Autism Spectr. Dis. 2011, 5:286-293.
268. Verity M.A. Manganese neurotoxicity: a mechanistic hypothesis. Neurotoxicology 1999, 20:489-497.
269. Veuthey T., Hoffmann D., Vaidya V.S., Wessling-Resnick M. Impaired renal function and development in Belgrade rats. Am. J. Physiol. Renal Phys. 2014, 306:F333-F343.
270. Vural H., Sirin B., Yilmaz N., Eren I., Delibas N. The role of arginine-nitric oxide pathway in patients with Alzheimer disease. Biol. Trace Elem. Res. 2009, 129:58-64.
271. Waalkes M.P. Cadmium carcinogenesis in review. J. Inorg. Biochem. 2000, 79:241-244.
272. Wang X., Garrick M.D., Yang F., Dailey L.A., Piantadosi C.A., et al. TNF, IFN-gamma, and endotoxin increase expression of DMT1 in bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L24-L33.
273. Wang X., Wu Y., Stonehuerner J.G., Dailey L.A., Richards J.D., et al. Oxidant generation promotes iron sequestration in BEAS-2B cells exposed to asbestos. Am. J. Respir. Cell. Mol. Biol. 2006, 34:286-292.
274. Wang X., Li G.J., Zheng W. Upregulation of DMT1 expression in choroidal epithelia of the blood-CSF barrier following manganese exposure in vitro. Brain Res. 2006, 1097:1-10.
275. Wang Q., Luo W., Zheng W., Liu Y., Xu H., et al. Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development. Toxicol. Appl. Pharmacol. 2007, 219:33-41.
276. Wang Q., Luo W., Zhang W., Dai Z., Chen Y., et al. Iron supplementation protects against lead-induced apoptosis through MAPK pathway in weanling rat cortex. Neurotoxicology 2007, 28:850-859.
277. Wasserman G.A., Liu X., Parvez F., Ahsan H., Levy D., et al. Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 2006, 114:124-129.
278. Wedler F.C., Denman R.B. Glutamine synthetase: the major Mn(II) enzyme in mammalian brain. Curr. Top. Cell Regul. 1984, 24:153-169.
279. Whitfield J.B., Zhu G., Heath A.C., Powell L.W., et al. Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin. Exp. Res. 2001, 25:1037-1045.
280. Wolff N.A., Ghio A.J., Garrick L.M., Garrick M.D., Zhao L., et al. Evidence for mitochondrial localization of divalent metal transporter 1 (DMT1). FASEB J. 2014.
281. Wong K.-L., Klaassen C.D. Neurotoxic effects of cadmium in young rats. Toxicol. Appl. Pharmacol. 1982, 63:330-337.
282. Wright R.O., Amarasiriwardena C., Woolf A.D., Jim R., Bellinger D.C. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology 2006, 27:210-216.
283. Wu J., Basha M.R., Brock B., Cox D.P., Cardozo-Pelaez F., et al. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J. Neurosci. 2008, 28:3-9.
284. Wysokinski D., Zaras M., Dorecka M., Waszczyk M., Szaflik J., et al. An association between environmental factors and the IVS4+44C>A polymorphism of the DMT1 gene in age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 2012, 250:1057-1065.
285. Xian-hui D., Wei-juan G., Tie-mei S., Hong-lin X., Jiang-tao B., et al. Age-related changes of brain iron load changes in the frontal cortex in APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease. J. Trace. Elem. Med. Biol. 2015, 30:118-123.
286. Yang Q., Jian J., Katz S., Abramson S.B., Huang X. 17beta-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 2012, 153:3170-3178.
287. Yanik M., Vural H., Tutkun H., Zoroglu S.S., Savas H.A., et al. The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2004, 254:43-47.
288. Ye Q., Kim J. Loss of hfe function reverses impaired recognition memory caused by olfactory manganese exposure in mice. Toxicol. Res. 2015, 31:17-23.
289. Yu L., Golbeck J., Yao J., Rusnak F. Spectroscopic and enzymatic characterization of the active site dinuclear metal center of calcineurin: implications for a mechanistic role. Biochemistry 1997, 36:10727-10734.
290. Yu Y., Rahmanto Y.S., Richardson D.R. Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy. Br. J. Pharmacol. 2012, 165:148-166.
291. Yuan Y., Jiang C.Y., Xu H., Sun Y., Hu F.F., et al. Cadmium-induced apoptosis in primary rat cerebral cortical neurons culture is mediated by a calcium signaling pathway. PLoS One 2013, 8:e64330.
292. Zhang Z.H., Zuo Q.H., Wu X.R. Effects of lipid peroxidation on GABA uptake and release in iron-induced seizures. Chin. Med. J. (Engl.) 1989, 102:24-27.
293. Zhang A.-S., Canonne-Hergaux F., Gruenheid S., Gros P., Ponka P. Use of Nramp2-transfected Chinese hamster ovary cells and reticulocytes from mk/mk mice to study iron transport mechanisms. Exp. Hematol. 2008, 36:1227-1235.
294. Zhang L., Hu R., Li M., Li F., Meng H., et al. Deferoxamine attenuates iron-induced long-term neurotoxicity in rats with traumatic brain injury. Neurol. Sci. 2013, 34:639-645.
295. Zheng W., Aschner M., Ghersi-Egea J.-F. Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol. Appl. Pharmacol. 2003, 192:1-11.
296. Zhou X.Y., Tomatsu S., Fleming R.E., Parkkila S., Waheed A., et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. 1998, 95:2492-2497.
297. Zidenberg-Cherr S., Keen C.L., Lonnerdal B., Hurley L.S. Superoxide dismutase activity and lipid peroxidation in the rat: developmental correlations affected by manganese deficiency. J. Nutr. 1983, 113:2498-2504.
298. Zoller H., Koch R.O., Theurl I., Obrist P., Pietrangelo A., et al. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 2001, 120:1412-1419.